Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine

Dennis G. Moledina, Chirag Parikh

Research output: Contribution to journalReview article

Abstract

Summary: Acute kidney injury (AKI) is a common complication in hospitalized patients and is associated with adverse short- and long-term outcomes. AKI is diagnosed by serum creatinine (SCr)-based consensus definitions that capture an abrupt decrease in glomerular filtration rate associated with AKI. However, SCr-based AKI definitions lack sensitivity and specificity for diagnosing structural kidney injury. Moreover, AKI is a heterogeneous condition consisting of distinct phenotypes based on its etiology, prognosis, and molecular pathways, and that may potentially require different therapies. SCr-based AKI definitions provide no information on these AKI phenotypes. This review highlights traditional and novel tools that overcome the limitations of SCr-based AKI definitions to improve AKI phenotyping.

Original languageEnglish (US)
Pages (from-to)3-11
Number of pages9
JournalSeminars in Nephrology
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Acute Kidney Injury
Creatinine
Serum
Phenotype
Glomerular Filtration Rate
Kidney
Sensitivity and Specificity
Wounds and Injuries

Keywords

  • AKI
  • biomarkers
  • creatinine
  • cystatin C
  • furosemide
  • IL-18
  • IL-6
  • KIM-1
  • L-FABP
  • NGAL
  • urinary casts
  • urine microscopy

ASJC Scopus subject areas

  • Nephrology

Cite this

Phenotyping of Acute Kidney Injury : Beyond Serum Creatinine. / Moledina, Dennis G.; Parikh, Chirag.

In: Seminars in Nephrology, Vol. 38, No. 1, 01.01.2018, p. 3-11.

Research output: Contribution to journalReview article

@article{0a5b86329443443e86286f6775a1230e,
title = "Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine",
abstract = "Summary: Acute kidney injury (AKI) is a common complication in hospitalized patients and is associated with adverse short- and long-term outcomes. AKI is diagnosed by serum creatinine (SCr)-based consensus definitions that capture an abrupt decrease in glomerular filtration rate associated with AKI. However, SCr-based AKI definitions lack sensitivity and specificity for diagnosing structural kidney injury. Moreover, AKI is a heterogeneous condition consisting of distinct phenotypes based on its etiology, prognosis, and molecular pathways, and that may potentially require different therapies. SCr-based AKI definitions provide no information on these AKI phenotypes. This review highlights traditional and novel tools that overcome the limitations of SCr-based AKI definitions to improve AKI phenotyping.",
keywords = "AKI, biomarkers, creatinine, cystatin C, furosemide, IL-18, IL-6, KIM-1, L-FABP, NGAL, urinary casts, urine microscopy",
author = "Moledina, {Dennis G.} and Chirag Parikh",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.semnephrol.2017.09.002",
language = "English (US)",
volume = "38",
pages = "3--11",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Phenotyping of Acute Kidney Injury

T2 - Beyond Serum Creatinine

AU - Moledina, Dennis G.

AU - Parikh, Chirag

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Summary: Acute kidney injury (AKI) is a common complication in hospitalized patients and is associated with adverse short- and long-term outcomes. AKI is diagnosed by serum creatinine (SCr)-based consensus definitions that capture an abrupt decrease in glomerular filtration rate associated with AKI. However, SCr-based AKI definitions lack sensitivity and specificity for diagnosing structural kidney injury. Moreover, AKI is a heterogeneous condition consisting of distinct phenotypes based on its etiology, prognosis, and molecular pathways, and that may potentially require different therapies. SCr-based AKI definitions provide no information on these AKI phenotypes. This review highlights traditional and novel tools that overcome the limitations of SCr-based AKI definitions to improve AKI phenotyping.

AB - Summary: Acute kidney injury (AKI) is a common complication in hospitalized patients and is associated with adverse short- and long-term outcomes. AKI is diagnosed by serum creatinine (SCr)-based consensus definitions that capture an abrupt decrease in glomerular filtration rate associated with AKI. However, SCr-based AKI definitions lack sensitivity and specificity for diagnosing structural kidney injury. Moreover, AKI is a heterogeneous condition consisting of distinct phenotypes based on its etiology, prognosis, and molecular pathways, and that may potentially require different therapies. SCr-based AKI definitions provide no information on these AKI phenotypes. This review highlights traditional and novel tools that overcome the limitations of SCr-based AKI definitions to improve AKI phenotyping.

KW - AKI

KW - biomarkers

KW - creatinine

KW - cystatin C

KW - furosemide

KW - IL-18

KW - IL-6

KW - KIM-1

KW - L-FABP

KW - NGAL

KW - urinary casts

KW - urine microscopy

UR - http://www.scopus.com/inward/record.url?scp=85033466668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033466668&partnerID=8YFLogxK

U2 - 10.1016/j.semnephrol.2017.09.002

DO - 10.1016/j.semnephrol.2017.09.002

M3 - Review article

C2 - 29291759

AN - SCOPUS:85033466668

VL - 38

SP - 3

EP - 11

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 1

ER -